Metabolomics: a global biochemical approach to the study of central nervous system diseases (Q37289766)

19 August 2017

1 reference

title

Metabolomics: a global biochemical approach to the study of central nervous system diseases (English)

1 reference

19 August 2017

1 reference

0 references

1

Rima Kaddurah-Daouk

1 reference

19 August 2017

K Ranga Rama Krishnan

series ordinal

2

1 reference

PubMed ID

18843269

19 August 2017

language of work or name

English

0 references

publication date

8 October 2008

1 reference

19 August 2017

Neuropsychopharmacology

1 reference

19 August 2017

34

1 reference

19 August 2017

1

1 reference

19 August 2017

173-186

1 reference

https://scigraph.springernature.com/pub.10.1038/npp.2008.174

19 August 2017

0 references

cites work

Beyond monoamines: glutamatergic function in mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

Neurochemistry and neuroendocrinology of schizophrenia: a selective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

Metabonomics in pharmaceutical R&D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

Pheno/genotypic correlations of neuronal ceroid lipofuscinoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

Peripheral blood markers of oxidative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

Evidence for lipase abnormality: high levels of free and triacylglycerol forms of unsaturated fatty acids in neuronal ceroid-lipofuscinosis tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Implications of lipid biology for the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Metabolomic profiling to develop blood biomarkers for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

GABAergic dysfunction in mood disorders.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Integrated application of transcriptomics and metabonomics yields new insight into the toxicity due to paracetamol in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Excessive stimulation of poly(ADP-ribosyl)ation contributes to endothelial dysfunction in pre-eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Metabolic flux analysis with a comprehensive isotopomer model in Bacillus subtilis

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Determination of full 13C isotopomer distributions for metabolic flux analysis using heteronuclear spin echo difference NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Serum uric acid levels and the risk of Parkinson disease

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Metabolites from cerebrospinal fluid in aneurysmal subarachnoid haemorrhage correlate with vasospasm and clinical outcome: a pattern-recognition 1H NMR study

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Presynaptic receptors for dopamine, histamine, and serotonin

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Extending the breadth of metabolite profiling by gas chromatography coupled to mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Low cerebrospinal fluid glutamate and glycine in refractory affective disorder.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

The neuronal ceroid-lipofuscinoses. Recent advances.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Neuronal ceroid lipofuscinoses caused by defects in soluble lysosomal enzymes (CLN1 and CLN2)

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Metabolic profiling of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Metabolomics: a global biochemical approach to drug response and disease

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Metabolomic mapping of atypical antipsychotic effects in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Metabolomics and systems biology: making sense of the soup

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

High-performance liquid chromatography separations coupled with coulometric electrode array detectors: a unique approach to metabolomics.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Increased cerebrospinal fluid glutamine levels in depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Serotonin and bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Selectivity and types of cell death in the neuronal ceroid lipofuscinoses

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Neurodegenerative disease: the neuronal ceroid lipofuscinoses (Batten disease).

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Recent advances in the neurobiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Genetics of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

De novo expansion of a (CAG)n repeat in sporadic Huntington's disease

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

A preliminary metabolomic analysis of older adults with and without depression.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

UPLC-ESI-TOFMS-based metabolomics and gene expression dynamics inspector self-organizing metabolomic maps as tools for understanding the cellular response to ionizing radiation.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

High resolution 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten disease

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Plasma GABA in affective illness. A preliminary investigation

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Metabolomic analysis and signatures in motor neuron disease

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Metabolomic identification of novel biomarkers of myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Machine learning for detection and diagnosis of disease

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Serotonin transporter gene variants and behavior: a comprehensive review

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Biogenic amines and affective disorders

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

A machine learning perspective on the development of clinical decision support systems utilizing mass spectra of blood samples

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia?

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Systematic identification of conserved metabolites in GC/MS data for metabolomics and biomarker discovery

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

https://api.crossref.org/works/10.1038%2FNPP.2008.174

1 reference

7 January 2021

Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Application of liquid chromatography-mass spectrometry analysis in metabolomics: reversed-phase monolithic capillary chromatography and hydrophilic chromatography coupled to electrospray ionization-mass spectrometry.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Metabolic profiling of plasma from discordant schizophrenia twins: correlation between lipid signals and global functioning in female schizophrenia patients.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

The art and practice of systems biology in medicine: mapping patterns of relationships

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Monitoring and managing weight gain in the mentally ill.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Biomarker discovery using high-dimensional lipid analysis

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

A GC-based metabonomics investigation of type 2 diabetes by organic acids metabolic profile.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.174

7 January 2021

Identifiers

DOI

10.1038/NPP.2008.174

1 reference

19 August 2017

1 reference

PubMed ID

18843269